GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicofarma Biotech SA (WAR:MDB) » Definitions » EV-to-FCF

Medicofarma Biotech (WAR:MDB) EV-to-FCF : 194.00 (As of May. 29, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Medicofarma Biotech EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Medicofarma Biotech's Enterprise Value is zł52.96 Mil. Medicofarma Biotech's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was zł0.27 Mil. Therefore, Medicofarma Biotech's EV-to-FCF for today is 194.00.

The historical rank and industry rank for Medicofarma Biotech's EV-to-FCF or its related term are showing as below:

WAR:MDB' s EV-to-FCF Range Over the Past 10 Years
Min: -781.49   Med: -22.92   Max: 517.39
Current: 213.92

During the past 13 years, the highest EV-to-FCF of Medicofarma Biotech was 517.39. The lowest was -781.49. And the median was -22.92.

WAR:MDB's EV-to-FCF is ranked worse than
93.94% of 528 companies
in the Drug Manufacturers industry
Industry Median: 23.61 vs WAR:MDB: 213.92

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-29), Medicofarma Biotech's stock price is zł0.78. Medicofarma Biotech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was zł-0.016. Therefore, Medicofarma Biotech's PE Ratio for today is At Loss.


Medicofarma Biotech EV-to-FCF Historical Data

The historical data trend for Medicofarma Biotech's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicofarma Biotech EV-to-FCF Chart

Medicofarma Biotech Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -59.05 -5.90 -64.65 -239.10 -314.54

Medicofarma Biotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -314.54 -52.69 -90.17 -51.52 236.33

Competitive Comparison of Medicofarma Biotech's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Medicofarma Biotech's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicofarma Biotech's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicofarma Biotech's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Medicofarma Biotech's EV-to-FCF falls into.



Medicofarma Biotech EV-to-FCF Calculation

Medicofarma Biotech's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=52.963/0.273
=194.00

Medicofarma Biotech's current Enterprise Value is zł52.96 Mil.
Medicofarma Biotech's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medicofarma Biotech  (WAR:MDB) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Medicofarma Biotech's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.78/-0.016
=At Loss

Medicofarma Biotech's share price for today is zł0.78.
Medicofarma Biotech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-0.016.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Medicofarma Biotech EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Medicofarma Biotech's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicofarma Biotech (WAR:MDB) Business Description

Traded in Other Exchanges
N/A
Address
ul. Soko?owska 9 lok. U19, Warsaw, POL, 01-142
Medicofarma Biotech SA operates in the pharmaceutical industry. The company specializes in contract manufacturing of medical devices, medicinal products and dietary supplements. The business is spread across Austria, Czech Republic, Spain, Ireland, Canada, Germany, Norway, Sweden, Great Britain, and Italy.